Skip to main content

Table 4 The extrapolated health care costs (in Swiss Francs) in IBD versus non-IBD patients between 2010 and 2014

From: Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014

Mean (CI, median) IBD non-IBD p a
2010
Total 9590 (9210-9970, 5390) 3160 (3140-3170, 750) <0.001
 Inpatient 2040 (1830-2240, 0) 890 (880-890, 0) <0.001
 Outpatient 3920 (3790-4040, 2810) 1510 (1500-1510, 490) <0.001
 Medication 3630 (3430-3840, 1700) 760 (760-770, 100) <0.001
2012
Total 11,680 (11,230-12,140, 6090) 3380 (3360-3390, 780) <0.001
 Inpatient 2080 (1860-2300, 0) 950 (940-960, 0) <0.001
 Outpatient 4470 (4300-4640, 3110) 1630 (1630-1640, 520) <0.001
 Medication 5130 (4840-5430, 1900) 790 (790-800, 110) <0.001
2014
Total 12,790 (12,270-13,300, 6810) 3540 (3520-3560, 870) <0.001
 Inpatient 2150 (1870-2430, 0) 910 (900-920, 0) <0.001
 Outpatient 5280 (5070-5490, 3510) 1830 (1830-1840, 610) <0.001
 Medication 5360 (5100-5620, 1900) 800 (790-800, 110) <0.001
  1. a p-values were calculated using multivariate linear regression (adjusted for age group, sex, and canton of residence)